Abstract:The emergence of clustered regularly interspaced short palindromic repeats (CRISPR)-based genome editing systems has led to the appreciation of CRISPR as a versatile and powerful gene-editing tool in the molecular biology laboratory and a potentially potent therapeutic for the treatment of a variety of intractable diseases. Nonetheless, one of the most onerous obstacles that restricts the wide availability of CRISPR technology from wide practical applications is the lack of appropriate delivery vehicles for the simultaneous transportation of multicomponent CRISPR systems to the intracellular targets. Herein, we attempted to create an intriguing nanometer-scaled vesicle platform (CRISPRsome) that, with the aid of a block copolymer of poly(ethylene glycol)-polylysine, simultaneously combined the fundamental components of the CRISPR system into the CRISPRsome, particularly the ribonucleic sgRNA and proteinic Cas9 endonuclease precisely located at the intermediate membrane and the internal reservoir regions of the nanometer-scaled vesicles, respectively. Furthermore, biofunctionalization strategies, including using redox-responsive disulfide linkages between lysine units to cross-link the well-defined CRISPRsome structures and surface functionalization with the cyclic Arg-Gly-Asp ligand to stimulate receptor-mediated endocytosis, were proposed in the well-defined CRISPRsome. The subsequent results validated its appreciable gene knockout efficacies toward cancerous cells with the green fluorescent protein (GFP) reporter gene, thereby highlighting the prosperous potential of CRISPRsome to facilitate the use of CRISPR technology in a variety of practical applications.

Purified Cas9 Fusion Proteins for Advanced Genome Manipulation

An Efficient Expression and Purification Protocol for SpCas9 Nuclease and Evaluation of Different Delivery Methods of Ribonucleoprotein

CRISPRs for Optimal Targeting: Delivery of CRISPR Components as DNA, RNA, and Protein into Cultured Cells and Single-Cell Embryos

A Robust Expression and Purification Method for Production of SpCas9-GFP-MBP Fusion Protein for In Vitro Applications

Fusion guide RNAs for orthogonal gene manipulation with Cas9 and Cpf1

Convergent Arrangement of sgRNA and Cas9 in CRISPRsome for Transcellular Trafficking

An Engineered Exosome for Delivering Sgrna:Cas9 Ribonucleoprotein Complex and Genome Editing in Recipient Cells.

Multiplex CRISPR/Cas9-based genome engineering from a single lentiviral vector

Genome engineering using the CRISPR-Cas9 system

Programmable repression and activation of bacterial gene expression using an engineered CRISPR-Cas system

Enhancing site-specific DNA integration by a Cas9 nuclease fused with a DNA donor-binding domain

A Transfection-Free Approach of Gene Editing via a gold-based nanoformulation of the Cas9 protein

Generation of Cell Lines Stably Expressing a dCas9-Fusion or sgRNA to Address Dynamics of Long-Term Effects of Epigenetic Editing

Efficient expression of multiple guide RNAs for CRISPR/Cas genome editing

Applications of Cas9 as an RNA-programmed RNA-binding protein

Cas9-Based Tools For Targeted Genome Editing And Transcriptional Control

Chimeric CRISPR-CasX enzymes and guide RNAs for improved genome editing activity

Establishment of Cell Lines Stably Expressing dCas9-Fusions to Address Kinetics of Epigenetic Editing

CRISPR-Cas systems for editing, regulating and targeting genomes

An optimized SpCas9 high-fidelity variant for direct protein delivery

Chapter Two - Expression and purification of cell-penetrating Cas9 and Cas12a enzymes for peptide-assisted genome editing